Login    Join free Add to favorites    中文
home > news > 3rd Biomarkers & Precision Medicine USA Congress
Industry Updates | New Products | Supplier News | Upcoming Events | business | web
3rd Biomarkers & Precision Medicine USA Congress

hits:382     Date:06/22/18

3rd Biomarkers & Precision Medicine USA Congress

Join Oxford Global's 2018 Biomarkers & Precision Medicine USA live webinar to get and in-depth overview of the processes and issues from taking a biomarker target from discovery through to commercialization.
 
"Moving Biomarkers from Bench into the Clinic"
Hosted by Xuemei Zhao, Senior Principal Scientist, Merck & Co., Inc & Qing Kang, Senior Scientist, Syros Pharmaceuticals
Thursday 28th June | 5pm BST
Can't make the date? Still register and the recording can be sent to you afterwards
 
 
Xuemei Zhao, Senior Pricipal Scientist,
Merck & Co., Inc
Xuemei is currently a Senior Principal Scientist in the Translational Molecular Biomarkers Department at Merck & Co., in Kenilworth, NJ. She received her Ph.D in Chemistry from Columbia University and performed her postdoctoral research at Cold Spring Harbor Laboratory.
 
Find out more: https://bit.ly/2tswPul
 
Qing Kang, Senior Scientist, Translational Medicine
Syros Pharmaceuticals
Qing Kang, Ph.D., has been in her current role as a Senior Scientist in Translational Medicine at Syros Pharmaceuticals, Inc. since March 2018. She serves as the science lead for an ongoing Phase 2 trial of SY-1425, its first-in-class oral, selective retinoic acid receptor alpha (RAR伪) agonist, in genomically defined subsets of patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).
 
Find out more: https://bit.ly/2tswPul
 
Benefits to Attend

This webinar will provide the opportunity to learn more about the challenges that need to be overcome in clinical biomarker development. You will also be able to learn more about the past, present and future uses of translational biomarkers in precision medicine.
 
R&D US Series
3 Events in One
Xuemei will also be presenting at the 2018 Biomarkers & Precision Medicine USA Congress on 11-12 October 2018, San Diego, USA. This event is co-located with our 5th Annual Drug Discovery & Chemistry USA Congress, and the inaugural Immuno-Oncology USA Congress to form part of the R&D US Series which will take place 11-12 October 2018, San Diego, USA.
 
Visit the website: https://bit.ly/2rd0SWE
To receive further information regarding the Congress, the registration fees and what discounts we have available please contact a.fernandez@oxfordglobal.co.uk
Related News>> more
advertisement

Copyright(C) 2006-2018 Bio-Equip    E-mail:web@bio-equip.cn   娌狪CP澶06040519鍙